Početna stranicaCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
106,05 $
Poslije radnog vremena:(0,0094 %)−0,010
106,04 $
Zatvoreno: 17. tra, 18:00:25 GMT -4 · USD · NYSE · Odricanje od odgovornosti
Preth. zaklj. cijena
104,25 $
Dnevni raspon
102,65 $ - 106,23 $
Godišnji raspon
91,86 $ - 254,15 $
Tržišna kapitalizacija
5,21 mlr. USD
Prosječna količina
1,91 mil.
P/E omjer
531,71
Prinos dividende
-
Glavno tržište vrijednosnica
NYSE
U vijestima
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
(USD) | pro 2024.info | Godišnja promjena |
---|---|---|
Prihod | 1,00 mlr. | −1,08 % |
Operativni troškovi | 235,66 mil. | 3,20 % |
Neto dohodak | −214,50 mil. | −214,65 % |
Neto profitabilnost | −21,39 | −215,87 % |
Zarada po dionici | 2,66 | 8,13 % |
EBITDA | 170,83 mil. | −17,24 % |
Efektivna porezna stopa | 1,40 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
(USD) | pro 2024.info | Godišnja promjena |
---|---|---|
Gotovinska i kratkoročna ulaganja | 194,61 mil. | −29,69 % |
Ukupna imovina | 7,53 mlr. | −8,13 % |
Ukupne obveze | 4,02 mlr. | −11,37 % |
Ukupni kapital | 3,51 mlr. | — |
Dionice u optjecaju | 51,14 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 1,54 | — |
Povrat imovine | 2,51 % | — |
Povrat kapitala | 3,03 % | — |
Tok novca
Neto promjena novca
(USD) | pro 2024.info | Godišnja promjena |
---|---|---|
Neto dohodak | −214,50 mil. | −214,65 % |
Gotovina od poslovanja | 159,36 mil. | −27,87 % |
Gotovina iz ulaganja | −76,10 mil. | 68,07 % |
Gotovina iz financiranja | −75,88 mil. | −161,41 % |
Neto promjena novca | −6,07 mil. | −105,11 % |
Slobodan tok novca | 69,58 mil. | 82,32 % |
Više
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories is often criticized by animal rights activists, who condemn the company's use of dogs and non-human primates for pharmaceutical research. The company is also a major harvester of blood from horseshoe crabs. Wikipedia
Glavni izvršni direktor
Osnovano
1947
Web-lokacija
Zaposlenici
19.400